Fridays weight loss is a telehealth provider that offers access to popular GLP-1 medications, including compounded versions ...

As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...

Like their injectable versions, GLP-1 pills can cause gastrointestinal issues. In the 2023 study, 80 percent of participants who took oral semaglutide for weight loss experienced gastrointestinal ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.

A new study from Rutgers University links higher body dissatisfaction, BMI, and maladaptive weight loss behaviors with ...

Glucagon-like peptide 1 receptor agonist therapy over a 12-month period is safe and effective in treating weight regain ...

If approved, orforglipron would offer an alternative to another GLP-1 pill, Rybelsus (semaglutide). That medication has been available by prescription since 2019 for the treatment of Type 2 diabetes ...

The rise of GLP-1 weight loss drugs represents a shift in the way consumers approach their health goals The rise of GLP-1 drugs for weight loss represents a remarkable shift in the way people ...

GLP-1 receptor agonists such as semaglutide and tirzepatide have proven to be highly effective in supporting weight loss by regulating appetite and metabolism. These medications work by mimicking ...

Losing weight isn’t just about counting ... of medically supported solutions has emerged—most notably, GLP-1 medications like Semaglutide, Tirzepatide, and even oral options that target ...